Sweden is poised to become the first country in the world to reach “smoke-free” status—defined as a smoking rate below 5%. According to newly released data, this achievement is not the product of prohibitionist measures but of pragmatic, evidence-based harm reduction policies, with nicotine pouches playing a central role—especially among women. The report Power in…
A newly published systematic review and network meta-analysis by La Rosa et al. (2025) offers valuable insights into the oral health effects of non-combustible nicotine products (NCNPs). As these products gain popularity as reduced-risk alternatives to smoking, understanding their broader health impact—including on oral health—is critical for clinicians, policymakers, and harm reduction advocates alike. The…
On January 7, 2025, the American Heart Association (AHA) released a comprehensive policy statement examining the cardiovascular health implications of smokeless oral nicotine products. Published in Circulation, the statement evaluates emerging products such as tobacco-free nicotine pouches, lozenges, gums, tablets, and gummies, many of which contain synthetic nicotine. This is the AHA’s first detailed update…
Sweden is on track to become the first country in Europe to achieve smoke-free status, defined as having fewer than 5% of the adult population smoking. Behind this milestone is a powerful shift in consumer behavior—particularly among women—driven by the rising popularity of oral nicotine pouches. A recent press release from Smoke-Free Sweden highlights how…
A new preprint study conducted by researchers at Emplicure provides promising evidence that bioceramic calcium sulfate-based nicotine pouches may offer faster and more efficient nicotine delivery than conventional cellulose-based formats. The findings, currently hosted on Research Square, could shape future innovations in nicotine pouch design and regulation. The study, titled Comparative study of calcium sulfate…
At the 2025 Global Forum on Nicotine in Warsaw, Emplicure Chief Clinical, Regulatory & Quality Officer Dr. Anna Franzén delivered a compelling presentation during the panel “Nicotine Pouches: What’s the Real Story?”. What Dr. Franzén Shared Dr. Franzén emphasised three critical pillars for nicotine pouches: Established safety of medicinal nicotine — highlighting how regulatory frameworks for nicotine…
As novel nicotine pouches continue to gain traction across global markets, questions around their contents and safety remain top of mind for regulators, public health experts, and adult consumers. A comprehensive study published in the journal Drug and Chemical Toxicology helps answer one of the most pressing questions: What’s actually inside these tobacco-free pouches? 🧪…
As novel nicotine products evolve, so too do the molecules behind them. One of the newest and most controversial is 6-methyl nicotine (6-MN)—a synthetic analog of nicotine that has now been detected in certain vaping devices and oral pouches. This compound, structurally similar to nicotine but chemically modified with a methyl group, may increase potency…
A newly updated systematic review and meta-analysis published in F1000Research delivers one of the most comprehensive evaluations to date on the relative risks of nicotine delivery products. The findings are timely—and critical—for public health officials, regulators, and harm reduction advocates working to reshape tobacco policy for the 21st century. 🔍 Study Overview Researchers reviewed 123…
As smoking rates remain stubbornly high across much of the Middle East and North Africa (MENA), health authorities and policymakers are exploring new ways to remember duce the region’s tobacco-related disease burden. One such possibility—oral nicotine pouches—is starting to enter the conversation. A recent article from Economy Middle East raises the question: Could these smoke-free…